Research To Practice | Oncology Videos

Latest Episodes:

Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute Nov 11, 2026

Show notes

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

Multiple Myeloma (0:00)
Introduction: ESMO 2026; Recent FDA Approvals (1:53)
Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
Bispecific Antibodies — Dr Lonial (19:16)
Antibody-Drug Conjugates — Dr Richardson (37:08)
Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

CME information and select publications

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute Nov 10, 2026

Show notes

Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics:

Introduction: ESMO 2026; Recent FDA Approvals (0:00)
Selection of Endocrine Therapy — Dr Antonarakis (2:24)
Utility of PARP Inhibitors — Dr Agarwal (22:59)
AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42)
Radiopharmaceuticals — Dr Agarwal (45:02)

CME information and select publications

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute Nov 09, 2026

Show notes

Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics:

Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00)
ER-Positive Breast Cancer (5:01)
HER2-Positive Breast Cancer (1:19:08)
Triple-Negative Breast Cancer (1:48:54)

CME information and select publications

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens Nov 06, 2026

Show notes

Featuring an interview with Dr Matthew Lunning, including the following topics:

Bispecific antibody/antibody-drug conjugate combinations (0:00)
A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

CME information and select publications

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program Nov 04, 2026

Show notes

Featuring a presentation by Dr Matthew Matasar, including the following topics:

Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
Discussion of Questions from the Community (50:20)

CME information and select publications

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis Nov 02, 2026

Show notes

Featuring an interview with Dr Matthew Lunning, including the following topics:

A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann LaCasce, MD, MMSc (0:00)
CNS prophylaxis in non-Hodgkin lymphoma (7:58)

CME information and select publications

Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity Oct 29, 2026

Show notes

Featuring an interview with Dr Erica Mayer, including the following topics:

Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00)
Investigator Survey Results on Risk Assessment and Genomic Assays (20:07)
Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30)
Investigator Survey Results on Adjuvant CDK4/6 Inhibitors (30:42)
Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (32:07)
Investigator Survey Results on Tolerability and Other Practical Considerations with Adjuvant CDK4/6 Inhibitor Therapy (37:44)
Adjuvant Oral Selective Estrogen Receptor Degraders (SERDs) for HR-Positive, HER2-Negative Localized Breast Cancer (39:05)
Investigator Survey Results on Adjuvant Oral SERDs (43:02)
Discussion of Questions from the Community (45:00)

CME information and select publications

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6 Oct 28, 2026

Show notes

Featuring perspectives from Dr Lindsey Roeker, including the following topics:

Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line venetoclax/obinutuzumab and experiences an excellent response (0:00)
Case: A man in his late 70s with small lymphocytic lymphoma (SLL) and cardiovascular comorbidities requiring verapamil and anticoagulation receives acalabrutinib/venetoclax; Case: A man in his early 80s with SLL receives zanubrutinib/sonrotoclax as part of the CELESTIAL-TNCLL trial (14:46)
Case: A man in his late 70s with progressive CLL worsening after a skiing injury receives acalabrutinib/venetoclax as part of the MAJIC trial (22:37)

CME information and select publications

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 5 Oct 28, 2026

Show notes

Featuring perspectives from Dr Lindsey Roeker, including the following topics:

Consensus Approach to optimizing front-line treatment (0:00)
Emerging role of sonrotoclax (8:39)
Bruton tyrosine kinase inhibitor monotherapy for older patients; discontinuation (14:48)
Evolving role of minimal residual disease assessment (19:16)

CME information and select publications

Ovarian Cancer — Microlearning Activity 4: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer Oct 27, 2026

Show notes

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

Case: A woman in her early 70s with endometrioid carcinoma of the ovary and a large solitary brain metastasis after primary debulking surgery and adjuvant carboplatin/paclitaxel — Professor Jonathan A Ledermann (0:00)

CME information and select publications